[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”Text” _builder_version=”4.21.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
September 20, 2022 | Toronto, ON<\/strong> \u2013 INOVAIT, the pan-Canadian network supported by\u00a0the Government of Canada\u2019s Strategic Innovation Fund, is pleased to announce additional recipients of its Pilot Fund. This competitive funding was awarded to further image-guided therapy (IGT) projects, including the integration of artificial intelligence (AI) and big data analytics to advance medical innovation.<\/p>\n A total of $3.4M in contributions were committed to supporting 28 new projects that involve collaborations between small- and medium-sized enterprises, hospital research centres, and academic institutions across the country. These organizations are each taking an innovative approach to using AI and data capabilities to enhance their IGT offerings, ultimately strengthening the sector and delivering health benefits to Canadians and people around the world. The 28 projects are worth a combined investment of $12.7M from all organizations involved, and INOVAIT is proud to contribute funding to help offset costs of some of the most innovative and impactful projects in the field.\u00a0<\/p>\n \u201cThis funding is designed to encourage the commercial translation of research and development, accelerate commercialization of products, facilitate the growth and expansion of firms, and advance industrial research and technology demonstration activities through collaboration,\u201d says Raphael Ronen, Co-Director of INOVAIT. \u201c<\/strong>With the first funding round now complete, a grand total of 40 projects have been funded, and $4.9M has been injected into Canada\u2019s image-guided therapy industry.\u201d<\/p>\n Funding was provided to projects that demonstrated the highest commercialization potential and economic impact, supporting members like Cohesic Inc. in Calgary, AB and Altis Labs in Toronto, ON.<\/p>\n <\/p>\n <\/p>\n \u201cCanada is a global leader in AI and image-guided therapy, and that wouldn\u2019t be possible without our world-leading innovative companies,\u201d says the Honourable Fran\u00e7ois-Philippe Champagne, Minister of Innovation, Science and Industry. \u201cBy supporting these projects, we are fostering new innovative medical solutions that will bring important benefits to Canadians.\u201d<\/p>\n INOVAIT will be announcing the details of a new call for applications for the Pilot Fund in the coming weeks. Visit our website<\/a> and join our mailing list for our latest announcements.\u00a0<\/p>\n For a full list of companies funded to date through INOVAIT, visit www.inovait.ca\/funding.<\/a><\/p>\n For any inquiries regarding INOVAIT or its programming, please reach out to\u00a0inovait@sunnybrook.ca .<\/a><\/p>\n <\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" September 20, 2022 | Toronto, ON \u2013 INOVAIT, the pan-Canadian network supported by\u00a0the Government of Canada\u2019s Strategic Innovation Fund, is pleased to announce additional recipients of its Pilot Fund. This competitive funding was awarded to further image-guided therapy (IGT) projects, including the integration of artificial intelligence (AI) and big data analytics to advance medical innovation. A total of $3.4M in contributions were committed to supporting 28 new projects that involve collaborations between small- and medium-sized enterprises, hospital research centres, and academic institutions across the country. These organizations are each taking an innovative approach to using AI and data capabilities to enhance their IGT offerings, ultimately strengthening the sector and delivering health benefits to Canadians and people around the world. The 28 projects are worth a combined investment of $12.7M from all organizations involved, and INOVAIT is proud to contribute funding to help offset costs of some of the most innovative and impactful projects in the field.\u00a0 \u201cThis funding is designed to encourage the commercial translation of research and development, accelerate commercialization of products, facilitate the growth and expansion of firms, and advance industrial research and technology demonstration activities through collaboration,\u201d says Raphael Ronen, Co-Director of INOVAIT. \u201cWith the first funding […]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"\n <\/p>\n\n\n\n (September 20, 2022 \u2013 Toronto, ON) <\/strong>\u2013 INOVAIT, the pan-Canadian network supported by the Government of Canada\u2019s Strategic Innovation Fund, is pleased to announce additional recipients of its Pilot Fund. This competitive funding was awarded to further image-guided therapy (IGT) projects, including the integration of artificial intelligence (AI) and big data analytics to advance medical innovation.<\/p>\n\n\n\n A total of $3.4M in contributions were committed to supporting 28 new projects that involve collaborations between small- and medium-sized enterprises, hospital research centres, and academic institutions across the country. These organizations are each taking an innovative approach to using AI and data capabilities to enhance their IGT offerings, ultimately strengthening the sector and delivering health benefits to Canadians and people around the world. The 28 projects are worth a combined investment of $12.7M from all organizations involved, and INOVAIT is proud to contribute funding to help offset costs of some of the most innovative and impactful projects in the field.<\/p>\n\n\n\n \u201cThis funding is designed to encourage the commercial translation of research and development, accelerate commercialization of products, facilitate the growth and expansion of firms, and advance industrial research and technology demonstration activities through collaboration,\u201d says Raphael Ronen, Co-Director of INOVAIT. \u201c<\/strong>With the first funding round now complete, a grand total of 40 projects have been funded, and $4.9M has been injected into Canada\u2019s image-guided therapy industry.\u201d<\/p>\n\n\n\n Funding was provided to projects that demonstrated the highest commercialization potential and economic impact, supporting members like Cohesic Inc. in Calgary, AB and Altis Labs in Toronto, ON.<\/p>\n\n\n\n \u201cCanada is a global leader in AI and image-guided therapy, and that wouldn\u2019t be possible without our world-leading innovative companies,\u201d says the Honourable Fran\u00e7ois-Philippe Champagne, Minister of Innovation, Science and Industry. \u201cBy supporting these projects, we are fostering new innovative medical solutions that will bring important benefits to Canadians.\u201d<\/p>\n\n\n\n INOVAIT will be announcing the details of a new call for applications for the Pilot Fund in the coming weeks. Visit www.inovait.ca<\/a> and join our mailing list for our latest announcements.<\/p>\n\n\n\n For a full list of companies funded to date through INOVAIT, visit www.inovait.ca\/funding.<\/a><\/p>\n\n\n\n\n
\n